Navigation Links


mesothelioma cancer


mesothelioma lawyers

pleural mesothelioma

peritoneal mesothelioma

malignant mesothelioma

mesothelioma asbestos

mesothelioma treatment

mesothelioma lawsuit

mesothelioma symptom

mesothelioma information

mesothelioma diagnosis

malignant pleural


mesothelioma law

mesothelioma law firm

mesothelioma litigation

mesothelioma definition

mesothelioma doctor

cause of mesothelioma

mesothelioma lawyer texas

mesothelioma settlement

mesothelioma help

mesothelioma injury

pericardial mesothelioma

mesothelioma research

lung cancer

benign tumors

Malignant Pleural Mesothelioma Cancer

Malignant pleural mesothelioma (aka Pleural  Mesothelioma, pleura mesothelioma) is mesothelioma cancer in the lining of the lungs (pleura) and in the respiratory areas of the body. There are two types of pleural mesothelioma. The first one is diffuse and malignant which is cancerous and the other one is localized and benign (non-cancerous). The benign mesothelioma can be removed surgically and are usually related to asbestos exposure. This type of mesothelioma is generally not dangerous. However, malignant (pleural) mesothelioma cancer is very dangerous unfortunately.

Malignant tumors are cancer, where the cancer cells can invade and damage tissues and organs near the tumor. Also, cancer cells can break away from a malignant tumor and enter the lymphatic system or the bloodstream. This is how cancer spreads from the original tumor to form new tumors in other parts of the body (aka metastasize).

Alimta (pemetrexed) in combination with cisplatin (Platinol) has recently been approved by the United States Food and Drug Administration (FDA) for the treatment of inoperable malignant mesothelioma. Alimta and cisplatin are the first drugs proven to improve the duration of survival for patients with advanced malignant mesothelioma cancer. People who develop malignant pleural mesothelioma have been exposed to asbestos particles by breathing or inhaling them in their work environment.



Sources of National Cancer Institute Information

Cancer Information Service
Toll-free: 1-800-4-CANCER (1-800-422-6237)
TTY (for deaf and hard of hearing callers): 1-800-332-8615

Contact Us

Copyright @ 2005 by